These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9489527)

  • 1. Neuropsychological prediction of dementia in Parkinson's disease.
    Mahieux F; Fénelon G; Flahault A; Manifacier MJ; Michelet D; Boller F
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):178-83. PubMed ID: 9489527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological profile of patients with Parkinson's disease without dementia.
    Janvin C; Aarsland D; Larsen JP; Hugdahl K
    Dement Geriatr Cogn Disord; 2003; 15(3):126-31. PubMed ID: 12584427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological deficits associated with driving performance in Parkinson's and Alzheimer's disease.
    Grace J; Amick MM; D'Abreu A; Festa EK; Heindel WC; Ott BR
    J Int Neuropsychol Soc; 2005 Oct; 11(6):766-75. PubMed ID: 16248912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease.
    Woods SP; Tröster AI
    J Int Neuropsychol Soc; 2003 Jan; 9(1):17-24. PubMed ID: 12570354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing.
    Barton BR; Bernard B; Czernecki V; Goldman JG; Stebbins G; Dubois B; Goetz CG
    Mov Disord; 2014 Sep; 29(10):1252-7. PubMed ID: 24821679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.
    Burdick DJ; Cholerton B; Watson GS; Siderowf A; Trojanowski JQ; Weintraub D; Ritz B; Rhodes SL; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Srivatsal S; Edwards KL; Montine TJ; Zabetian CP; Leverenz JB
    Mov Disord; 2014 Sep; 29(10):1258-64. PubMed ID: 25073717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
    Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
    Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological characteristics of preclinical dementia in Parkinson's disease.
    Jacobs DM; Marder K; Côté LJ; Sano M; Stern Y; Mayeux R
    Neurology; 1995 Sep; 45(9):1691-6. PubMed ID: 7675228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of cognitive impairment in advanced Parkinson's disease.
    Vingerhoets G; Verleden S; Santens P; Miatton M; De Reuck J
    J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):793-6. PubMed ID: 12754355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which factors predict cognitive decline in Parkinson's disease?
    Caparros-Lefebvre D; Pécheux N; Petit V; Duhamel A; Petit H
    J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):51-5. PubMed ID: 7823067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease.
    Kaszás B; Kovács N; Balás I; Kállai J; Aschermann Z; Kerekes Z; Komoly S; Nagy F; Janszky J; Lucza T; Karádi K
    Parkinsonism Relat Disord; 2012 Jun; 18(5):553-6. PubMed ID: 22405839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.